ArticleBMC microbiology2026
Molecular and enzymatic insights into biocontrol-mediated resistance against Zucchini yellow mosaic virus in squash (Cucurbita pepo L.).
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squash (Cucurbita pepo L.) is a major vegetable crop in Egypt and is highly vulnerable to Zucchini yellow mosaic virus (ZYMV), which causes severe mosaic, yellowing, and stunting symptoms. In this study, ZYMV was isolated from symptomatic squash plants in Kafr El-Sheikh Governorate and confirmed by RT-PCR and sequencing (GenBank Accession No. PV833355). The antiviral efficacy of two microbial biocontrol formulations-Bio-Nagi (Trichoderma asperellum) and Bio-4 (a Bacillus spp. consortium)-was assessed through foliar application and seed priming at pre-, concurrent-, and post-inoculation timings. Disease severity analyses showed that Bio-4 applied concurrently reduced symptom development by 62%, while Bio-Nagi pre-treatment resulted in a 48% reduction. Transmission electron microscopy revealed substantial protection of chloroplast and nuclear ultrastructure in Bio-4-treated plants compared with infected controls. Antioxidant enzyme activities (SOD and POD) increased by 1.8-2.4-fold following microbial treatments, indicating enhanced physiological defense responses. qRT-PCR profiling demonstrated strong differential induction of defense genes: PR1 was upregulated 5.6-fold in Bio-Nagi pre-treated plants, whereas PR3 and PR5 increased by 7-9-fold in Bio-4 concurrent and post-inoculation treatments. Overall, Bio-4 and Bio-Nagi mitigated ZYMV-associated symptoms and activated host defense pathways in squash. These findings underscore the importance of application timing and support microbial biocontrol agents as sustainable strategies for ZYMV management in squash production systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.